CLAUDIA BOBAY: Open Payments
NPI 1932188539 · SOUTH WHITLEY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$905 in 39 payments from 12 companies in 2025. Trend: 2023 $388 · 2024 $279 · 2025 $905
Food & beverage: $905
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $298 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $173 |
| Novo Nordisk Inc | 3 | $67 |
| Teva Pharmaceuticals USA, Inc. | 3 | $66 |
| ABBVIE INC. | 4 | $65 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Abbott Laboratories | 2 | $47 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Amgen Inc. | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: NURTEC ODT, CAPLYTA, ZAVZPRET, Wegovy, AUSTEDO XR, Auvelity, FREESTYLE LIBRE 3, UBRELVY.
Industry payments across IN — which companies pay providers there.
